Alerts
PDF
Other content recommended for you
- Clinical Research From Proposal to Implementation
- Can an ethics officer role reduce delays in research ethics approval? A mixed-method evaluation of an improvement project
- Understanding Food and Drug Administration Regulatory Requirements for an Investigational Device Exemption for Sponsor-Investigators
- SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
- Multicentre trials review process by research ethics committees in Spain: where do they stand before implementing the new European regulation?
- Analysis of warning letters issued by the US Food and Drug Administration to clinical investigators, institutional review boards and sponsors: a retrospective study
- 6ER-023 The role of institutional review boards, and hospital pharmacists as members, in the informed consent process in clinical research: a retrospective observational study
- Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries
- A rationale and framework for seeking remote electronic or phone consent approval in endovascular stroke trials – special relevance in the COVID-19 environment and beyond
- Results of a self-assessment tool to assess the operational characteristics of research ethics committees in low- and middle-income countries